Lyu, T. and Zhang, Y. (2020) “Targeting leukemia stem cells in unfit acute myeloid leukemia with a CD70-directed third agent: promise and caveats from the ELEVATE trial. Comment on: ‘Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study’”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.302003.